Expand BRTX Menu
BRTX MENU

BRTX Latest Press Releases

-- June 25, 2026 --

BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform Globe Newswire 8:15 AM

-- June 18, 2026 --

BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth Globe Newswire 8:15 AM

-- May 27, 2026 --

Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX) PRNewswire 7:45 AM

-- May 26, 2026 --

BioRestorative Completes Phase 2 Dosing of BRTX-100, Advancing Lead Regenerative Spine Program Toward 2027 Topline Data Globe Newswire 11:00 AM

-- May 13, 2026 --

BioRestorative Therapies Presents New Preclinical Data at ISCT 2026 Highlighting Source-Specific Exosome Functionality and Commercial Applications in BioCosmeceuticals Globe Newswire 11:00 AM

-- May 7, 2026 --

BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease Globe Newswire 12:00 PM

-- April 30, 2026 --

BioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical Platform Globe Newswire 10:36 AM

-- April 21, 2026 --

BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical Platform Globe Newswire 8:00 AM

-- April 7, 2026 --

BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform Globe Newswire 8:15 AM

-- March 30, 2026 --

BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease Globe Newswire 8:00 AM

-- March 19, 2026 --

BioRestorative Therapies to Present Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes